TY - JOUR
T1 - Differential stepwise evolution of SARS coronavirus functional proteins in different host species
AU - Tang, Xianchun
AU - Li, Gang
AU - Vasilakis, Nikos
AU - Zhang, Yuan
AU - Shi, Zhengli
AU - Zhong, Yang
AU - Wang, Lin Fa
AU - Zhang, Shuyi
N1 - Funding Information:
We are very grateful to Drs. Yi Guan, Ronald C. Montelaro, and Honglin Chen for critical review of the manuscript. This work was supported by the State Key Program for Basic Research grant (2005CB523004), the Sixth Framework Program EPISARS from the European Commission (no. 51163) to S.Z and a grant (07DZ22940) from the Shanghai government to S.Z. NV was supported by a grant by the Fine Foundation.
PY - 2009
Y1 - 2009
N2 - Background. SARS coronavirus (SARS-CoV) was identified as the etiological agent of SARS, and extensive investigations indicated that it originated from an animal source (probably bats) and was recently introduced into the human population via wildlife animals from wet markets in southern China. Previous studies revealed that the spike (S) protein of SARS had experienced adaptive evolution, but whether other functional proteins of SARS have undergone adaptive evolution is not known. Results. We employed several methods to investigate selective pressure among different SARS-CoV groups representing different epidemic periods and hosts. Our results suggest that most functional proteins of SARS-CoV have experienced a stepwise adaptive evolutionary pathway. Similar to previous studies, the spike protein underwent strong positive selection in the early and middle phases, and became stabilized in the late phase. In addition, the replicase experienced positive selection only in human patients, whereas assembly proteins experienced positive selection mainly in the middle and late phases. No positive selection was found in any proteins of bat SARS-like-CoV. Furthermore, specific amino acid sites that may be the targets of positive selection in each group are identified. Conclusion. This extensive evolutionary analysis revealed the stepwise evolution of different functional proteins of SARS-CoVs at different epidemic stages and different hosts. These results support the hypothesis that SARS-CoV originated from bats and that the spill over into civets and humans were more recent events.
AB - Background. SARS coronavirus (SARS-CoV) was identified as the etiological agent of SARS, and extensive investigations indicated that it originated from an animal source (probably bats) and was recently introduced into the human population via wildlife animals from wet markets in southern China. Previous studies revealed that the spike (S) protein of SARS had experienced adaptive evolution, but whether other functional proteins of SARS have undergone adaptive evolution is not known. Results. We employed several methods to investigate selective pressure among different SARS-CoV groups representing different epidemic periods and hosts. Our results suggest that most functional proteins of SARS-CoV have experienced a stepwise adaptive evolutionary pathway. Similar to previous studies, the spike protein underwent strong positive selection in the early and middle phases, and became stabilized in the late phase. In addition, the replicase experienced positive selection only in human patients, whereas assembly proteins experienced positive selection mainly in the middle and late phases. No positive selection was found in any proteins of bat SARS-like-CoV. Furthermore, specific amino acid sites that may be the targets of positive selection in each group are identified. Conclusion. This extensive evolutionary analysis revealed the stepwise evolution of different functional proteins of SARS-CoVs at different epidemic stages and different hosts. These results support the hypothesis that SARS-CoV originated from bats and that the spill over into civets and humans were more recent events.
UR - http://www.scopus.com/inward/record.url?scp=65449167637&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65449167637&partnerID=8YFLogxK
U2 - 10.1186/1471-2148-9-52
DO - 10.1186/1471-2148-9-52
M3 - Article
C2 - 19261195
AN - SCOPUS:65449167637
SN - 1471-2148
VL - 9
JO - BMC Evolutionary Biology
JF - BMC Evolutionary Biology
IS - 1
M1 - 52
ER -